| Dr Bilal Nawaz Khan, MD | |
|
600 Elizabeth St, Corpus Christi, TX 78404-2235 | |
| (361) 881-3000 | |
| (361) 881-3149 |
| Full Name | Dr Bilal Nawaz Khan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 16 Years |
| Location | 600 Elizabeth St, Corpus Christi, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114187747 | NPI | - | NPPES |
| 70802 | Other | AZ | ARIZONA LICENSE NUMBER |
| Q0775 | Other | TX | TEXAS LICENSE NUMBER |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Seton Hays | Kyle, TX | Hospital |
| Cedar Park Regional Medical Center | Cedar park, TX | Hospital |
| Seton Northwest Hospital | Austin, TX | Hospital |
| Stormont Vail Hospital | Topeka, KS | Hospital |
| Saint Barnabas Medical Center | Livingston, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usacs Critical Care Medicine Services Of Texas Pllc | 1153681796 | 38 |
News Archive
Two studies being presented at the American Academy of Ophthalmology's 2007 Annual Meeting suggest that telemedicine may have a significant role to play in the diagnosis of eye diseases, increased patient compliance and patient access to quality care.
Achieving universal access to HIV/AIDS treatment was a major focus Wednesday at the XVI International AIDS Conference in Toronto, and World Health Organization HIV/AIDS Director Kevin De Cock reported significant increases in the number of HIV-positive people with access to antiretroviral drugs.
As she was planning her study to look into the role physical activity and sport play in the development of substance addiction, Laurie de Grace was forewarned that she may have trouble finding any recovering addicts with a sporting background to speak with.
Oncolytics Biotech Inc. today announced that it has received approval from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that was agreed to by U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA).
Prostate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis.
› Verified 6 days ago
| Entity Name | Austin Critical Care Specialists Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447435805 PECOS PAC ID: 1052497187 Enrollment ID: O20080328000560 |
News Archive
Two studies being presented at the American Academy of Ophthalmology's 2007 Annual Meeting suggest that telemedicine may have a significant role to play in the diagnosis of eye diseases, increased patient compliance and patient access to quality care.
Achieving universal access to HIV/AIDS treatment was a major focus Wednesday at the XVI International AIDS Conference in Toronto, and World Health Organization HIV/AIDS Director Kevin De Cock reported significant increases in the number of HIV-positive people with access to antiretroviral drugs.
As she was planning her study to look into the role physical activity and sport play in the development of substance addiction, Laurie de Grace was forewarned that she may have trouble finding any recovering addicts with a sporting background to speak with.
Oncolytics Biotech Inc. today announced that it has received approval from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that was agreed to by U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA).
Prostate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis.
› Verified 6 days ago
| Entity Name | Lhp Texas Md Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841562667 PECOS PAC ID: 8527222108 Enrollment ID: O20120611000636 |
News Archive
Two studies being presented at the American Academy of Ophthalmology's 2007 Annual Meeting suggest that telemedicine may have a significant role to play in the diagnosis of eye diseases, increased patient compliance and patient access to quality care.
Achieving universal access to HIV/AIDS treatment was a major focus Wednesday at the XVI International AIDS Conference in Toronto, and World Health Organization HIV/AIDS Director Kevin De Cock reported significant increases in the number of HIV-positive people with access to antiretroviral drugs.
As she was planning her study to look into the role physical activity and sport play in the development of substance addiction, Laurie de Grace was forewarned that she may have trouble finding any recovering addicts with a sporting background to speak with.
Oncolytics Biotech Inc. today announced that it has received approval from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that was agreed to by U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA).
Prostate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis.
› Verified 6 days ago
| Entity Name | Usacs Critical Care Medicine Services Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023522554 PECOS PAC ID: 1153681796 Enrollment ID: O20180131000123 |
News Archive
Two studies being presented at the American Academy of Ophthalmology's 2007 Annual Meeting suggest that telemedicine may have a significant role to play in the diagnosis of eye diseases, increased patient compliance and patient access to quality care.
Achieving universal access to HIV/AIDS treatment was a major focus Wednesday at the XVI International AIDS Conference in Toronto, and World Health Organization HIV/AIDS Director Kevin De Cock reported significant increases in the number of HIV-positive people with access to antiretroviral drugs.
As she was planning her study to look into the role physical activity and sport play in the development of substance addiction, Laurie de Grace was forewarned that she may have trouble finding any recovering addicts with a sporting background to speak with.
Oncolytics Biotech Inc. today announced that it has received approval from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that was agreed to by U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA).
Prostate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis.
› Verified 6 days ago
| Entity Name | Conner Intensivist Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154980332 PECOS PAC ID: 0446587927 Enrollment ID: O20190806002774 |
News Archive
Two studies being presented at the American Academy of Ophthalmology's 2007 Annual Meeting suggest that telemedicine may have a significant role to play in the diagnosis of eye diseases, increased patient compliance and patient access to quality care.
Achieving universal access to HIV/AIDS treatment was a major focus Wednesday at the XVI International AIDS Conference in Toronto, and World Health Organization HIV/AIDS Director Kevin De Cock reported significant increases in the number of HIV-positive people with access to antiretroviral drugs.
As she was planning her study to look into the role physical activity and sport play in the development of substance addiction, Laurie de Grace was forewarned that she may have trouble finding any recovering addicts with a sporting background to speak with.
Oncolytics Biotech Inc. today announced that it has received approval from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that was agreed to by U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA).
Prostate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bilal Nawaz Khan, MD 6300 La Calma Dr Ste 200, Austin, TX 78752-3825 Ph: (512) 452-8533 | Dr Bilal Nawaz Khan, MD 600 Elizabeth St, Corpus Christi, TX 78404-2235 Ph: (361) 881-3000 |
News Archive
Two studies being presented at the American Academy of Ophthalmology's 2007 Annual Meeting suggest that telemedicine may have a significant role to play in the diagnosis of eye diseases, increased patient compliance and patient access to quality care.
Achieving universal access to HIV/AIDS treatment was a major focus Wednesday at the XVI International AIDS Conference in Toronto, and World Health Organization HIV/AIDS Director Kevin De Cock reported significant increases in the number of HIV-positive people with access to antiretroviral drugs.
As she was planning her study to look into the role physical activity and sport play in the development of substance addiction, Laurie de Grace was forewarned that she may have trouble finding any recovering addicts with a sporting background to speak with.
Oncolytics Biotech Inc. today announced that it has received approval from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that was agreed to by U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA).
Prostate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis.
› Verified 6 days ago
Dr. Natalie W Philbrick, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3301 S Alameda St Ste 201, Corpus Christi, TX 78411 Phone: 361-857-2900 | |
Dr. Gregg Lee Silverman, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 613 Elizabeth St, Suite 402, Corpus Christi, TX 78404 Phone: 361-887-2900 Fax: 361-887-0942 | |
Dr. Stanley Cal, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4918 Ayers St Ste 130, Corpus Christi, TX 78415 Phone: 361-400-4355 Fax: 888-815-1095 | |
James Michael Neff, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 7121 S Padre Island Dr, Corpus Christi, TX 78412 Phone: 361-696-6200 Fax: 361-696-6054 | |
Dr. John Douglas Pappas, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1521 S Staples St Ste 700, Corpus Christi, TX 78404 Phone: 361-888-8271 Fax: 361-885-3699 | |
Thomas Alexander, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1202 3rd St, Corpus Christi, TX 78404 Phone: 361-883-3962 Fax: 361-883-5398 | |
Marie Charisse Impe, NP Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 5802 Saratoga Blvd Ste 200, Corpus Christi, TX 78414 Phone: 361-696-6200 |